These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 33849729)

  • 1. Reply to Zhongzhong Chen, Hua Xie, and Fang Chen's Letter to the Editor re: Vuthy Ea, Anne Bergougnoux, Pascal Philibert, et al. How Far Should We Explore Hypospadias? Next-generation Sequencing Applied to a Large Cohort of Hypospadiac Patients. Eur Urol 2021;79:507-15.
    Bergougnoux A; Ea V; Paris F; Kalfa N
    Eur Urol; 2021 Jul; 80(1):e12-e13. PubMed ID: 33849729
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Vuthy Ea, Anne Bergougnoux, Pascal Philibert, et al. How Far Should We Explore Hypospadias? Next-generation Sequencing Applied to a Large Cohort of Hypospadiac Patients. Eur Urol 2021;79:507-515.
    Chen Z; Xie H; Chen F
    Eur Urol; 2021 Jul; 80(1):e10-e11. PubMed ID: 33838961
    [No Abstract]   [Full Text] [Related]  

  • 3. Reply to Ye Lei, Serdar Yildiz, and Minfeng Chen's Letter to the Editor re: James J. Hsieh, David Chen, Patricia Wang, et al. Genomic Biomarkers of a Randomized Trial Comparing First-line Everolimus and Sunitinib in Patients with Metastatic Renal Cell Carcinoma. Eur Urol 2017;71:405-14.
    Hsieh JJ; Marker M; Chen D
    Eur Urol; 2017 Sep; 72(3):e74-e75. PubMed ID: 28111113
    [No Abstract]   [Full Text] [Related]  

  • 4. Reply to Ruobing Lei, Yuehuan Li, and Yaolong Chen's Letter to the Editor re: Katharina Beyer, Lisa Moris, Michael Lardas, et al. Updating and Integrating Core Outcome Sets for Localised, Locally Advanced, Metastatic, and Nonmetastatic Castration-resistant Prostate Cancer: An Update from the PIONEER Consortium. Eur Urol 2022;81:503-14. Improving the Methodological Quality of Prostate Cancer Core Outcome Sets in Future Updates.
    Beyer K; MacLennan S; Van Hemelrijck M
    Eur Urol; 2022 Sep; 82(3):e68-e69. PubMed ID: 35688663
    [No Abstract]   [Full Text] [Related]  

  • 5. Reply to Lei Kang, Lugang Huang and Jingti Zhang's Letter to the Editor re: Omar Fahmy, Mohd Ghani Khairul-Asri, Christian Schwentner, et al. Algorithm for Optimal Urethral Coverage in Hypospadias and Fistula Repair: A Systematic Review. Eur Urol 2016;70:293-8.
    Gakis G; Fahmy O
    Eur Urol; 2017 May; 71(5):e155-e156. PubMed ID: 27916203
    [No Abstract]   [Full Text] [Related]  

  • 6. Reply to Meny Lv, Xufei Luo, and Yaolong Chen's Letter to the Editor re: Mauro Gacci, Vasileios I. Sakalis, Markos Karavitakis, et al. European Association of Urology Guidelines on Male Urinary Incontinence. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.05.012.
    Gacci M; Sakalis VI; Karavitakis M; Gravas S
    Eur Urol; 2022 Oct; 82(4):e119-e120. PubMed ID: 35945088
    [No Abstract]   [Full Text] [Related]  

  • 7. Reply to Thomas Zilli, Gilles Créhange and Olivier Chapet's Letter to the Editor re: Pascal Rischmann, Albert Gelet, Benjamin Riche, et al. Focal High Intensity Focused Ultrasound of Unilateral Localized Prostate Cancer: A Prospective Multicentric Hemiablation Study of 111 Patients. Eur Urol 2017;71:267-73.
    Rischmann P
    Eur Urol; 2017 Jul; 72(1):e15-e16. PubMed ID: 28089305
    [No Abstract]   [Full Text] [Related]  

  • 8. Reply to Francesco Montorsi and Giorgio Gandaglia's Letter to the Editor re: Riccardo Autorino, Homayoun Zagar, Mirandolino B. Mariano, et al. Perioperative Outcomes of Robotic and Laparoscopic Simple Prostatectomy: A European-American Multi-institutional Analysis. Eur Urol 2015;68:86-94; Re: Matthew Bultitude, Ben Challacombe. Simple Prostatectomy: A Step Too Far for Laparoscopy? Eur Urol 2015;68:95-6. Eur Urol 2015;68:e7-8.
    Autorino R; Zargar H; Porpiglia F
    Eur Urol; 2015 Jul; 68(1):e9-10. PubMed ID: 25666848
    [No Abstract]   [Full Text] [Related]  

  • 9. Reply to Pascal Mouracade's Letter to the Editor re: Giorgio Gandaglia, Nicola Fossati, Armando Stabile, et al. Radical Prostatectomy in Men with Oligometastatic Prostate Cancer: Results of a Single-institution Series with Long-term Follow-up. Eur Urol 2017;72:289-92. Do the Data Violate Kaplan-Meier Assumptions?
    Gandaglia G; Fossati N; Montorsi F; Briganti A
    Eur Urol; 2017 Aug; 72(2):e31. PubMed ID: 28214034
    [No Abstract]   [Full Text] [Related]  

  • 10. Reply to Xiangyang Yao, Chen Duan, Bo Li, Xiaoliang Wu and Hua Xu's Letter to the Editor Re: Hilda A. de Barros, Matthias N. van Oosterom, Maarten L. Donswijk, et al. Robot-assisted Prostate-specific Membrane Antigen-radioguided Salvage Surgery in Recurrent Prostate Cancer Using a DROP-IN Gamma Probe: The First Prospective Feasibility Study. Eur Urol 2022;82:97-105.
    de Barros HA; van Oosterom MN; Donswijk ML; Hendrikx JJMA; Vis AN; Maurer T; van Leeuwen FWB; van der Poel HG; van Leeuwen PJ
    Eur Urol; 2023 Jan; 83(1):e13-e14. PubMed ID: 36272945
    [No Abstract]   [Full Text] [Related]  

  • 11. Reply to Anju Murayama's Letter to the Editor re: David-Dan Nguyen, Liam Murad, Anne Xuan-Lan Nguyen, et al. Industry Payments to American Editorial Board Members of Major Urology Journals. Eur Urol. Eur Urol. 2023;84:442-43.
    Nguyen DD; Nguyen AV; Murad L; Labban M; Trinh QD; Wallis CJD; Bhojani N
    Eur Urol; 2023 Dec; 84(6):e140-e141. PubMed ID: 37770285
    [No Abstract]   [Full Text] [Related]  

  • 12. Reply to Carissa E. Chu, Peter E. Lonergan, and Peter R. Carroll's Letter to the Editor re: Vasilis Stavrinides, Francesco Giganti, Bruce Trock, et al. Five-year Outcomes of Magnetic Resonance Imaging-based Active Surveillance for Prostate Cancer: A Large Cohort Study. Eur Urol 2020;78:443-51.
    Stavrinides V; Giganti F; Emberton M; Moore CM
    Eur Urol; 2020 Sep; 78(3):e112-e113. PubMed ID: 32653326
    [No Abstract]   [Full Text] [Related]  

  • 13. Reply to Erik Rud and Eduard Baco's Letter to the Editor re: Re: Jeffrey C. Weinreb, Jelle O. Barentsz, Peter L. Choyke, et al. PI-RADS Prostate Imaging - Reporting and Data System: 2015, Version 2. Eur Urol 2016;69:16-40.
    Barentsz JO; Choyke PL; Cornud F; Haider MA; Macura KJ; Margolis D; Shtern F; Padhani AR; Tempany CM; Thoeny HC; Verma S; Weinreb JC
    Eur Urol; 2016 Nov; 70(5):e137-e138. PubMed ID: 27130148
    [No Abstract]   [Full Text] [Related]  

  • 14. Reply to M.V. Meng's Letter to the Editor re: H. Baumert et al. The use of polymer (Hem-o-lok) clips for management of the renal hilum during laparoscopic nephrectomy. Eur Urol 2006;49:816-9 and P.L. Steinberg et al. re: H. Baumert et al. The use of polymer (Hem-o-lok) clips for management of the renal hilum during laparoscopic nephrectomy. Eur Urol 2006;49:816-9. Eur Urol 2007;51:572-3.
    O'Kane HF; Nambirajan T
    Eur Urol; 2007 May; 51(5):1449. PubMed ID: 17229516
    [No Abstract]   [Full Text] [Related]  

  • 15. Reply to Valeria Panebianco, Francesco Del Giudice, Yoshifumi Narumi, Giuseppe Simone, Ettore De Berardinis, and James Catto's Letter to the Editor re: Helena Vila-Reyes, G. Joel De Castro, and James M. McKiernan's Letter to the Editor re: Yunjin Bai, Yubo Yang, and Yin Tang's Letter to the Editor re: Andrea Necchi, Marco Bandini, Giuseppina Calareso, et al. Multiparametric Magnetic Resonance Imaging as a Noninvasive Assessment of Tumor Response to Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer: Preliminary Findings from the PURE-01 Study. Eur Urol 2020; 77:636-43. Eur Urol 2020;77:e158: Can mpMRI Replace Conventional Transurethral Resection of Bladder Cancer? Eur Urol 2021;79:e35-e36.
    Vila-Reyes H; Joel DeCastro G; McKiernan JM
    Eur Urol; 2021 Feb; 79(2):e54-e55. PubMed ID: 33248798
    [No Abstract]   [Full Text] [Related]  

  • 16. Reply to Pirus Ghadjar and Thomas Wiegel's Letter to the Editor re: Abdenour Nabid, Nathalie Carrier, André-Guy Martin, et al. Duration of Androgen Deprivation Therapy in High-risk Prostate Cancer: A Randomized Phase III Trial. Eur Urol 2018;74:432-31.
    Nabid A; Souhami L
    Eur Urol; 2019 Mar; 75(3):e63. PubMed ID: 30773206
    [No Abstract]   [Full Text] [Related]  

  • 17. Reply to Pascal Mouracade's letter to the editor re: R. Houston Thompson, Tom Atwell, Grant Schmit, et al. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses. Eur Urol 2015;67:252-9.
    Thompson RH; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Psutka SP; Stewart SB; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC
    Eur Urol; 2015 Oct; 68(4):e84-5. PubMed ID: 26058957
    [No Abstract]   [Full Text] [Related]  

  • 18. Reply to Daniela Wittmann, Ted A. Skolarus' Letter to the Editor re: Neil E. Martin, Laura Massey, Caleb Stowell, et al. Defining a Standard Set of Patient-centered Outcomes for Men with Localized Prostate Cancer. Eur Urol 2014;67:460-7.
    Martin NE; Stowell C
    Eur Urol; 2016 Jun; 69(6):e127. PubMed ID: 26873843
    [No Abstract]   [Full Text] [Related]  

  • 19. Reply to Jovo Bogdanović and Vuk Sekulić's Letter to the Editor re: Firas Abdollah, Giorgio Gandaglia, Nazareno Suardi, et al. More Extensive Pelvic Lymph Node Dissection Improves Survival in Patients with Node-positive Prostate Cancer. Eur Urol 2015;67:212-9.
    Abdollah F; Montorsi F; Briganti A
    Eur Urol; 2015 Aug; 68(2):e37-8. PubMed ID: 25801052
    [No Abstract]   [Full Text] [Related]  

  • 20. Reply to Byung Kwan Park's Letter to the Editor re: Baris Turkbey, Andrew B. Rosenkrantz, Masoom A. Haider, et al. Prostate Imaging Reporting and Data System Version 2.1: 2019 Update of Prostate Imaging Reporting and Data System Version 2. Eur Urol 2019;76:329-40.
    Rosenkrantz AB; Turkbey B; Barentsz J; Weinreb JC
    Eur Urol; 2019 Sep; 76(3):e79. PubMed ID: 31182228
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.